Speech, language and perception are complex behaviours impacted by disease and changes in brain health.
Effective communication is driven by a subtle balance between motor and cognitive-linguistic systems. Dysfunction in these domains often dramatically impacts social relationships, employability and activities of daily living. Taking a clinically informed approach to data collection and analysis ensures Redenlab are not just analysing data, but capitalizing on decades of research experience and expertise to improve your trial protocols and clinical interpretation.
Areas of Expertise
Parkinson’s & Huntington’s Disease
Parkinson’s and Huntington’s disease both lead to significant in changes to speech. Redenlab can aid in condition assessment and the objective measurement of treatment outcomes.
Learn more about Parkinson’s Disease
Learn more about Huntington’s Disease
Ataxia
In hereditary ataxia, speech intelligibility, quality, control, and perception decline over time. Redenlab are world leaders in the measurement of speech and swallowing in ataxia.
Dementia
Communication is frequently compromised in many forms dementia. The complexity of these disorders can be documented and tracked through intelligent speech and language protocols. Redenlab hold expertise in Alzheimer’s disease and fronto-temporal dementias.
Depression
Depression is a serious mental health condition that can have a significant effect on people’s lives. Speech is a viable marker of progression and treatment response. Redenlab has extensive experience in multi-site clinical trials of depression
Alertness & Fatigue
Managing risks due to alertness and fatigue is important for many industries. Redenlab are developing novel algorithms and systems for detecting alertness and fitness-for-duty.
Neurodevelopment (pediatric)
Characterizing and successfully monitoring speech and language ability in children with predominantly verbal, minimally verbal or non-verbal presentations is challenging. Redenlab hold extensive expertise in testing neurodevelopmental populations from ASD to rare genetic disorders.